Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae

Farid El Garch1, Ann Lismond, Laura J V Piddock

  • 1Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.

Abstract

Insights

The ABC efflux system PatA/PatB in Streptococcus pneumoniae is induced by fluoroquinolones, potentially increasing resistance. This induction may involve the competence pathway, highlighting a new mechanism for antibiotic resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Fluoroquinolone resistance in Streptococcus pneumoniae is often mediated by active efflux pumps.
  • Two primary efflux systems identified are PmrA (major facilitator superfamily) and PatA/PatB (ABC transporters).

Purpose of the Study:

  • To investigate the inducibility of pmrA, patA, and patB gene expression in response to subinhibitory fluoroquinolone concentrations.
  • To understand the role of these efflux systems in fluoroquinolone resistance.

Main Methods:

  • Studied wild-type, resistant clinical isolates, and efflux mutants of Streptococcus pneumoniae.
  • Determined Minimum Inhibitory Concentrations (MICs) for various fluoroquinolones.
  • Quantified gene expression of pmrA, patA, and patB using real-time PCR after exposure to sub-MIC fluoroquinolones.

Main Results:

  • Resistant strains showed increased MICs and elevated patA/patB expression, which decreased upon disruption of these genes or addition of reserpine.
  • Exposure to all tested fluoroquinolones reversibly induced patA and patB expression, but not pmrA.
  • Mitomycin C, a known inducer of competence, also upregulated patA and patB expression.

Conclusions:

  • The PatA/PatB ABC efflux system is induced by sub-minimum inhibitory concentrations of fluoroquinolones.
  • This induction, potentially linked to competence pathway activation, contributes to fluoroquinolone resistance in Streptococcus pneumoniae.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...